[Effect of weight reduction programme on C-peptide concentration and lipid profile in obese children aged 4 to 10

Joanna Gajewska1, Witold Klemarczyk, Jadwiga Ambroszkiewicz

  • 1Zakład Badań Przesiewowych, Instytut Matki i Dziecka w Warszawie. biochem.imid@imid.med.pl

Medycyna Wieku Rozwojowego
|April 6, 2011
PubMed

Insights

Weight reduction in obese children improves lipid profiles and C-peptide levels, aiding metabolic syndrome prevention. This lifestyle intervention is crucial for prepubertal children with abnormal lipid profiles.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Metabolic Disorders

Background:

  • Childhood obesity is linked to metabolic syndrome and cardiovascular risk factors.
  • Limited research exists on weight reduction's impact on atherogenic risk in prepubertal children.

Purpose of the Study:

  • To evaluate C-peptide concentration and lipid profiles in obese prepubertal children.
  • To assess changes before and after a weight reduction therapy program.

Main Methods:

  • A 3-month lifestyle intervention (diet, physical activity, behavior therapy) was applied to 52 obese children (aged 4-10).
  • Anthropometric, C-peptide, and lipid profile parameters were measured pre- and post-intervention.
  • A reference group of 30 healthy children was included for comparison.

Main Results:

  • Obese children who lost weight (Group A) showed significant decreases in triglycerides and C-peptide levels.
  • No significant biochemical changes were observed in obese children without weight loss (Group B).
  • Group B exhibited a slight increase in total and LDL-cholesterol.

Conclusions:

  • Weight reduction programs are essential for prepubertal obese children to prevent metabolic syndrome.
  • The study supports the benefits of weight reduction programs when accepted by children and families.
  • C-peptide may serve as a useful marker for monitoring therapy effectiveness in managing childhood obesity.
Abstract

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...